Cormorant Asset Management, LP Elevation Oncology, Inc. Transaction History

Cormorant Asset Management, LP

  • $1.43 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$1.03 - $1.53 $32,070 - $47,638
-31,136 Reduced 1.57%
1,952,032 $2.21 Million
Q2 2022

Aug 15, 2022
BUY
$1.26 - $3.94 $3 - $11
3 Added 0.0%
1,983,168 $2.78 Million
Q2 2021

Aug 16, 2021
BUY
$11.44 - $13.57 $22.7 Million - $26.9 Million
1,983,165 New
1,983,165 $25.6 Million

Others Institutions Holding ELEV

# of Institutions
68
Shares Held
45.4M
Call Options Held
700
Put Options Held
27.6K
View Full List

About Elevation Oncology, Inc.

ELEV Quotes by TradingView
  • Ticker ELEV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,300,900
  • Market Cap $12.3M
  • Description
  • Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...
More about ELEV
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email